BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY
Patent №
US 9,726,669
Granted
2017-08-08
Filed 2010
Owner
PROMETHEUS LABORATORIES INC.
+3 more
Lab
—
AI components
1
evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
12854144
The present invention provides compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in cells such as tumor cells. Information on the expression and/or activation states of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
AI classification
Ownership
PROMETHEUS LABORATORIES INC.
assignment · 255560182
DIATECH HOLDINGS, INC.
assignment · 420450220
PIERIAN HOLDINGS, INC.
namechg · 430860831
NESTEC S.A.
assignment · 483220411
Assignors
KIM, PHILLIP, LIU, XINJUN, KIRKLAND, RICHARD, LEE, TANI, YBARRONDO, BELEN, SINGH, SHARAT
On an employer assignment, the assignors are typically the inventors.